SEARCH

SEARCH BY CITATION

References

  • Ashton, F. E., Michon, F., Bundle, D., Gidney, M., Gamian, A. and Jennings, H. J., Immunological properties of monoclonal antibodies to the N-propionyl derivative of group B meningococcal polysaccharide. In: M.Achtman, P.Kohl, C.Marchal, G.Morelli, G.Seiler, and B.Theisen (eds.), Proceedings of the Seventh International Pathogenic Neisseria Conference “NEISSERIA 1990,” pp. 187191, Walter de Gruyter, Berlin (1991).
  • Bernhard, H., Roth, S., Bauerschmitz, J., Meyer von Büschenfelde, K.-H. and Dippold, W., Immunorecognition of ganglioside epitopes on human normal and melanoma tissues. Int. J. Cancer, 51, 568572 (1992).
  • Bremer, E. G., Levery, S. B., Sonnino, S., Ghidoni, R., Canevari, S., Kannagi, R. and Hakomori, S., Characterization of a glycosphingolipid antigen defined by the monoclonal antibody Mbr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J. biol. Chem., 259, 1477314777 (1984).
  • Brezicka, F. T., Olling, S., Nilsson, O., Bergh, J., Holmgren, J., Sorenson, S., Yngvason, F. and Lindholm, L., Immunohistological detection of fucosyl-GM1 ganglioside in human lung cancer and normal tissues with monoclonal antibodies. Cancer Res., 49, 13001305 (1989).
  • Cheresh, D. A., Varki, A. P., Varki, N. M., Stallcup, W. B., Levine, J. and Reisfeld, R. A., A monoclonal antibody recognizes O-acylated sialic acid in a human melanoma-associated ganglioside. J. biol. Chem., 259, 74537459 (1984).
  • Cheung, N.-K. V., Lazarus, H., Miraldi, F. D., Abramowaky, C. R., Kallic, S., Saarinen, U. M., Spitzer, T., Strandjord, S. E., Coccia, P. F. and Berger, N. A., Ganglioside GD2 specific monoclonal antibody 3F8: a phase-I study in patients with neuroblastoma and malignant melanoma. J. clin. Oncol., 5, 14301440 (1987).
  • Cheung, N.-K. V., Saarinen, U. M., Neely, J. E., Landmeier, B., Donovan, D. and Coccia, P. F., Monoclonal antibody to a glycolipid antigen on human neuroblastoma cells. Cancer Res., 45, 26422649 (1985).
  • Dippold, W. G., Dienes, H. P., Knuth, A. and Meyer von Büschenfelde, K.-H., Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues. Cancer Res., 45, 36993705 (1985).
  • Dippold, W. G., Lloyd, K. O., Li, L. T., Ikeda, H., Oettgen, H. F. and Old, L. J., Cell-surface antigens of human malignant melanoma: definition of six antigenic systems with monoclonal antibodies. Proc. nat. Acad. Sci. (Wash.), 77, 61146118 (1980).
  • Dohi, T., Ohta, S., Hanai, N., Yamaguchi, K. and Oshima, M., Sialylpentaosylceramide detected with anti-GM2 monoclonal antibody. J. biol. Chem., 265, 78807885 (1990).
  • Feizi, T., Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens. Nature (Lond.), 314, 5357 (1985).
  • Finn, O. J., Immunotherapy: tumor vaccines. Proc. Amer. Assoc. Cancer Res., 36, 675 (1995).
  • Frosch, M., Gorgen, I., Boulnois, G. J., Timmis, K. N., and Bitter-Suermann, D., NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc. nat. Acad. Sci. (Wash.), 82, 11941198 (1985).
  • Gilewski, T., Adluri, R., Houghton, A., Norton, L. and Livingston, P., Preliminary results: vaccination of breast cancer patients lacking indentifiable disease with MUC1-keyhole limpet hemocyanin (KLH) conjugate and QS21. Amer. Soc. Clin. Oncol. Proc., 15, 555 (1996).
  • Hamilton, W. B., Helling, F. and Livingston, P. O., Ganglioside expression on sarcoma and small cell lung cancer carcinoma compared to tumors of neuroectodermal origin (abstract). Proc. Amer. Assoc. Cancer Res., 34, 491 (1993a).
  • Hamilton, W. B., Helling, F., Lloyd, K. O. and Livingston, P. O., Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography. Int. J. Cancer, 53, 566573 (1993b).
  • Hayrinen, J., Jennings, H., Raff, H. V., Rougon, G., Hanai, N., Gerardy-Schahn, R. and Finne, J., Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides. J. infect. Dis., 171, 14811490 (1995).
  • Houghton, A. N., Mintzer, D., Cordon-Cardo, C., Welt, S., Fliegel, B., Vadhan, S., Carswell, E., Melamed, M. R., Oettgen, H. F. and Old, L. J., Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase-I trial in patients with malignant melanoma. Proc. nat. Acad. Sci. (Wash.), 82, 12421246 (1985).
  • Hsu, S. M., Rain, L. and Fanger, H., Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577580 (1981).
  • Husmann, M., Roth, J., Kabat, E. A., Weisgerber, C., Frosch, M. and Bitter-Suermann, D., Immunohistochemical localization of polysialic acid in tissue sections: differential binding to polynucleotides and DNA of a murine IgG and a human IgM monoclonal antibody. J. Histochem. Cytochem., 38, 209215 (1990).
  • Irie, R. F. and Morton, D. L., Regression of cutaneous metastatic melanoma by introlesional injection with human monoclonal antibody to ganglioside GD2. Proc. nat. Acad. Sci. (Wash.), 83, 86948698 (1986).
  • Kriep, B., Flegel, W. A., Northoff, H. and Rieber, E. P., CDw60 glycolipid antigens of human leukocytes: structural characterization and cellular distribution. Blood, 82, 17761786 (1993).
  • Livingston, P. O., Construction of cancer vaccines with carbohydrate and protein (peptide) tumor antigens. Curr. Opin. Immunol., 4, 624629 (1992).
  • Livingston, P. O., Wong, G. Y. C., Adluri, S., Tao, Y., Padavan, M., Parente, R., Hanlon, C., Calves, M. J., Helling, F., Ritter, G., Oettgen, H. F. and Old, L. J., Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside. J. clin. Oncol., 12, 10361044 (1994).
  • MacLean, G. D., Reddish, M., Koganty, R. R., Wong, T., Gandhi, S., Smolenski, M., Samuel, J., Nabholtz, J. M. and Longenecker, B. M., Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol. Immunother., 36, 215222 (1993).
  • MacLean, G. D., Yacyshyn-Bowen, M. B., Samuel, J., Meikle, A., Stuart, G., Nation, J., Poppema, S., Jerry, M., Koganty, R. R., Wong, T. and Longenecker, B. M., Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J. Immunother., 11, 292296 (1992).
  • Ménard, S., Tagliabue, E., Canevari, S., Fossati, G. and Colnaghi, M. I., Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res., 43, 12951300 (1983).
  • Nilsson, O., Brezicka, F. T., Holmgren, J., Sorenson, S., Svennerholm, L., Yngvason, F. and Lindholm, L., Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1. Cancer Res., 46, 14031407 (1986).
  • Nishinaka, Y., Ravindranath, M. H. and Irie, R. F., Development of a human monoclonal antibody to ganglioside GM2 with potential for cancer treatment. Cancer Res., 56, 56665671 (1996).
  • Ritter, G., Boosfeld, E., Markstein, E., Yu, R. K., Ren, S., Oettgen, J. F., Old, L. J. and Livingston, P. O., Biochemical and serological characteristics of natural 9-O-acetyl GD3 from human melanoma and bovine buttermilk and chemically O-acetylated GD3. Cancer Res., 50, 14031410 (1990).
  • Saleh, M. N., Khazaeli, M. B., Wheeler, R. H., Dropcho, E., Liu, T., Urist, M., Miller, D. M., Lawson, S., Dixon, P., Russell, C. H. and LoBuglio, A. F., Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. Cancer Res., 52, 43424347 (1992).
  • Scheidegger, E. P., Lackie, P. M., Papay, J. and Roth, J., In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. Lab. Invest., 70, 95106 (1994).
  • Schlom, J., Eggensperger, D., Colcher, D., Molinolo, A., Houchen, D., Miller, L. S., Hinkle, G. and Siler, K., Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates. Cancer Res., 52, 10671072 (1992).
  • Shitara, K., Fujiwara, K., Igarashi, S., Ohta, S., Furuya, A., Nakamura, K., Koike, M. and Hanai, N., Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG. J. immunol. Methods, 169, 8392 (1994).
  • Svennerholm, L., Chromatographic separation of human brain gangliosides. J. Neurochem., 10, 613623 (1963).
  • Troy, F. A., Polysialylation: from bacteria to brains. Glycobiology, 2, 523 (1992).
  • Zhang, S., Helling, F., Lloyd, K. O. and Livingston, P. O., Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides. Cancer Immunol. Immunother., 40, 8894 (1995).